On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on PRs and Gain Exclusive Benefits with NNW Prime! Click to View Details
ThursdayOct 06, 2016 12:39 pm

SinglePoint, Inc.’s (SING) Text2Bid is Anchor in $18B Auction Industry

SinglePoint (OTC: SING) is a holding company focused on acquiring small to mid-sized companies with mobile technologies. One fruit of this business model is the company’s Text2Bid mobile bidding platform, an asset obtained through the Company’s acquisition of Mobile Bidding Technologies (MBT) in 2015. Text2Bid has established a recognizable name in the broader $18 billion auction industry with a track record of turning normal auctions into interactive experiences, with a yearly average increase of 28% in total amount donated, as compared to previous years without the solution. To view the full article, visit: http://nnw.fm/2NUAz About SinglePoint, Inc. SinglePoint, Inc. is…

Continue Reading

ThursdayOct 06, 2016 12:32 pm

Inventergy Global, Inc. (INVT) Prices $6M Public Offering

As part of its plan of compliance with NASDAQ, Inventergy Global, Inc. (NASDAQ: INVT) this morning priced a registered public offering of $1 per common stock and warrant for gross proceeds of approximately $6.0 million. The IP company said it plans to use the net proceeds of the offering to redeem a portion of its outstanding Series C and Series E preferred stock and to fund operations. Company management also expects that approximately $5.3 million of the public offering will result in the company's stockholders' equity exceeding the NASDAQ requirement of $2.5 million. The warrants are exercisable immediately and for…

Continue Reading

WednesdayOct 05, 2016 12:48 pm

Immunomedics, Inc. (IMMU) Prices Underwritten Offering

Immunomedics (NASDAQ: IMMU) has priced an underwritten offering of 10 million shares of common stock and warrants to purchase up to 10 million shares of common stock at $3 per share for anticipated gross proceeds of $30 million. The company said it will use the proceeds from the offering to support clinical and regulatory activities for IMMU-132, including submission of a New Drug Application to the Food and Drug Administration for accelerated approval in metastatic triple-negative breast cancer, as well as for working capital and general corporate purposes. To view the full press release, visit: http://nnw.fm/vPH7a About Immunomedics, Inc. Immunomedics…

Continue Reading

MondayOct 03, 2016 12:49 pm

FTE Networks, Inc. (FTNW) Guides for $55M in Revenues on Strong Project Pipeline

FTE Networks (OTCQX: FTNW) this morning provided 12-month revenue guidance and pegged its current contract pipeline at approximately $166 million. The network infrastructure solutions provider said it expects the contracted projects – awarded during the first nine months of 2016 - to generate in excess of $55 million in annualized revenue from 2017 to 2019. "We will continue to see a ramp up in revenues as we head into 2017 and beyond as our new management team works on a number of new higher margin initiatives such as Compute-to-the-Edge which is the next wave of telecom. We are currently engaged…

Continue Reading

Contact us: 212.418.1217